Abstract
Multiple genetic changes take place during tumor development and progression. These genetic changes result in inactivation of tumor suppressor genes and activation of proto-oncogenes. Frequent genetic changes observed in gliomas are losses of chromosomal regions on 9p, 10q, 13q, 17p and on 22. Loss of 10q is seen in more than 80% of the glioblastoma multiforme (GBM) tumors suggesting the presence of a gene critical for GBM formation on this chromosome. Amplification of epidermal growth factor receptor gene and expression of platelet derived growth factor and fibroblast growth factor genes are also common among gliomas. The most common genetic abnormality found in medulloblastomas is loss of 17p. The C-myc gene is amplified in a few primary tumors, but the incidence of amplification is higher in medulloblastoma derived cell lines. These findings suggest that the same two genetic processes, gene amplification and regional chromosomal loss, which characterize other primitive childhood neuroectodermal tumors such as retinoblastoma and neuroblastoma are also important in medulloblastomas.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bishop JM: The molecular genetics of cancer. Science 235: 305–311, 1987
Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49: 3713–3721, 1989
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990
Vogelstein B, Fearon E, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 319: 525–532, 1988
Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R: Allelotype of colorectal carcinomas. Science 244: 207–211, 1989
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49–56, 1990
Kinzler KW, Nilbert MF, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hamilton SR, Hedge P, Markham A, Carlson M, Joslyn G, Groden J, White R, Miki Y, Miyoshi Y, Nishisho I, Nakamura Y: Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251: 1366–1370, 1991
Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechine D, Finniear R, Markaham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y: Identification of FAP locus genes from chromosome 5q21. Science 253: 661–665, 1991
Weston A, Willey JC, Modali R, Sugimura H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trump BF, Harris CC: Differential DNA sequence deletions from chromosomes 3, 11, 13 and 17 in squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 86: 5099–5103, 1989
Tsai YC, Nichols PW, Hiti AL, Skinner DG, Jones PA: Allelic losses of chromosome 9, 11 and 17 in human bladder cancer. Cancer Res 50: 44–47, 1990
Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87: 8751–8755, 1990
Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa R, Nakagama H, Harada H, Yagua M, Matsubara K, Nakamura Y: Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89–93, 1991
Bigner SH, Vogestein B: Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathology 1: 12–18, 1990
Bigner SH, Mark J, Bigner DD: Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47: 141–154, 1990
Rey JA, Bello MJ, De Campos JM, Kusak ME, Ramos C, Benitez J: Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29: 201–221, 1987
Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW: A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39: 253–279, 1989
James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WB: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551, 1988
Fults D, Pedone CA, Thomas GA, White R: Allelotype of human malignant astrocytoma. Cancer Res 50: 5784–5789, 1990
Fujimoto M, Fults DW, Thomas GA, Nakamura Y, Heilbrun MP, White R, Story JL, Naylor SL, Kagan-Hallet KS, Sheridan PJ: Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4: 210–214, 1989
Watanabe K, Nagai M, Wakai S, Arai T, Kawashima K: Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathologica 80: 251–254, 1990
Jenkins RB, Ransom DT, Ritland SR, Moertel CA, Dahl RJ, O'Fallon JR, Scheithauer B, Kelly PJ, Kimmel DW: Correlation of cytogenetic and loss of heterozygosity studies of chromosome 10 in gliomas. Cancer Genet Cytogenet (Abstract, in press), 1991
Rasheed BKA, Fuller GN, Friedman AH, Bigner DD, Bigner SH: Loss of heterozygosity for 10q loci in human gliomas (submitted)
Steck PA, Pershouse MA, Hadi A, Stubblefield E, Yung WKA: Partial reversion of tumorigenic phenotype of human glioblastoma cells (LG-11) by microcell-mediated transfer of chromosome 10. Proceedings of the American Association for Cancer Research 32: 1691 (Abstract), 1991
Pershouse MA, Steck PA, Hadi A, Killary AM, Yung WKA, Stubblefield E: Functional analysis of reinsertion of chromosome 10 into human glioblatoma (U251) cells. Proceedings of the American Association for Cancer Research. 32: 1839 (Abstract), 1991
Simpson NE, Cann H: Report of the committee on the genetic constitution of chromosome 10. Human Gene Mapping 10.5. Cytogenet Cell Genet 55: 142–152, 1990
Parmiter AH, Balaban G, Clark WH, Nowell PC: Possible involvement of the chromosome region 10q24-q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet 30: 313–317, 1988
Stanbridge EJ: Human tumor suppressor genes. Ann Rev Genet 24: 615–657, 1990
Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, Gedde-Dahl T, Cavenee WK: Osteosarcoma and retinoblastoma: a shared mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82: 6216–6220, 1985
James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK: Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86: 2858–2862, 1989
Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, Noble MD: Retinoblastoma gene deletions in human glioblastomas. Oncogene 6: 445–448, 1991
El-Azouzi M, Chung RY, Farmer GE, Martuza RL, Black PM, Rouleau GA, Hettlich C, Hedley-Whyte ET, Zervas NT, Panagopoulos K, Nakamura Y, Gusella JF, Seozinger BR: Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci USA 86: 7186–7189, 1989
Fults D, Tippets RH, Thomas GA, Nakamura Y, White R: Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 45: 6572–6577, 1989
Mackay J, Steel CM, Elder PA, Forrest APM, Evans HJ: Allele loss on short arm of chromosome 17 in breast cancer. Lancet 2: 1384–1385, 1988
Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217–221, 1989
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins F, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumor types. Nature 342: 705–708, 1989
Chung RY, Whaley JM, Anderson KM, Freiman RN, Menon AG, Seizinger BR: p53 gene mutations in human glioblastomas associated with early age onset and better survival. Proceedings of the American Association for Cancer Research. 31: 6 (Abstract), 1990
Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87: 6166–6170, 1990
Miyakoshi J, Dobler KD, Allalunis-Turner, McKean JDS, Petruk K, Allen PBR, Aronyk KN, Weir B, Huyser-Wierenga D, Fulton D, Urtasun RC, Day RS: Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular insensitivity to interferons. Cancer Res 50: 278–283, 1990
Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD: Homozygous deletion of the α-and β1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85: 5259–5263, 1988
James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK, Collins VP: Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors. Cancer Res 51: 1684–1688, 1991
Olopade OI, Jenkins R, Linnenbach AJ, Cowan JM, Pomykala H, Rowley JD, Diaz MO: Molecular analysis of chromosome 9p deletion in human solid tumors. Proceedings of the American Association for Cancer Research 31: 1883 (Abstract), 1990
Ransom D, Jenkins R, Olopade F, Diaz M, Ritland S, Bren CT: Loss of chromosome 10 alleles and loss of α-interferon genes in human gliomas. Proceedings of the American Association for Cancer Research 31: 224 (Abstract), 1990
Seizinger BR, de la Monte S, Atkins L, Gusella JF, Martuza RL: Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci USA 84: 5419–5423, 1987
Rouleau GA, Wertelecki W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger BR, Martuza RL, Superneau DW, Conneally PM, Gusella JF: Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329: 246–248, 1987
Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863–5867, 1991
Rouleau GA, Seizinger BR, Wertelecki W, Haines JL, Supeneau DW, Martuza RL, Gusella JF: Flanking markers bracket the neurofibromatosis type 2 (NF-2) gene. Am J Hum Genet 46: 323–328, 1990
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger JH: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147, 1985
Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B: Increased expression of epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899–6903, 1987
Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH: Amplification and expression of the epidermal growth factor receptor gene in human glioma and xenografts. Cancer Res 48: 2231–2238, 1988
Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamota T, Taniguchi S, Shibuya M: Amplification of the structurally and functionally altered epidermal growth factor (c-erbB) receptor gene in human brain tumors. Mol Cell Biol 8: 1816–1820, 1988
Malden LT, Novak U, Kay AH, Burgess AW: Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48: 2711–2714, 1988
Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP: Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomasin vivo. Cancer Res 51: 2164–2172, 1991
Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD: Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 87: 4207–4211, 1990
Sugawa N, Ekstrand AJ, James CD, Collins VP: Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87: 8602–8606, 1990
Filmus J, Pollak MN, Cairncross JG, Buick RN: Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. Biochem Biophys Res Commun 131: 207–215, 1985
Wells A, Bishop JM, Helmeste D: Amplified gene for epidermal growth factor receptor in a human glioblastoma cell line encodes an enzymatically inactive protein. Mol Cell Biol 8: 4561–4565, 1988
Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD: Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 50: 8017–8022, 1990
Nister M, Libermann TA, Betsholz C, Petterson M, Claesson-Welsh L, Schlessinger J, Westermark B: Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910–3919, 1988
Maxwell M, Naber SP, Wolfe HJ, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN: Coexpression of platelet derived growth factor (PDGF) and PDGF receptor genes by primary human astroctytomas may contribute to their development and maintenance. J Clin Invest 85: 131–140, 1990
Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710–5714, 1990
Lichtor T, Dohrmann GJ, Gurney ME: Cytokine gene expression by human gliomas. Neurosurgery 26: 788–793, 1990
Birchmeier C, Sharma S, Wigler M: Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc Natl Acad Sci USA 84: 9270–9274, 1987
Wu JK, Chikaraishi DM: Differential expression of ros oncogene in primary human astrocytomas and astrocytoma cell lines. Cancer Res 50: 3032–3035, 1990
Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B: Identification of an amplified, highly expressed gene in a malignant glioma. Science 236: 70–73, 1987
Kinzler KW, Ruppert JM, Bigner SH, Vogelstein B: The Gli gene is a member of the kruppel family of zinc finger proteins. Nature 332: 371–374, 1988
Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B: Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83: 470–473, 1986
Gerosa MA, Talarico D, Fognani C, Raimondi E, Colombatti M, Tridente G, De Carli L, Valle GD: Over-expression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Cander Inst 81: 63–67, 1989
Heisterkamp N, Morris C, Sender L, Knoppel E, Uribe L, Cui M-Y, Groffen J: Rearrangement of the human Abl oncogene in glioblastoma. Cancer Res 50: 3429–3434, 1990
Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30: 91–101, 1988
Griffith CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BS: Chromosome abnormalities in pediatric brain tumors. Cancer Res 48: 175–180, 1988
Raffel C, Gilles FE, Weinberg KI: Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. Cancer Res 50: 587–591, 1990
Thomas GA, Raffel C: Loss of heterozygosity on 6q, 16q and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51: 639–643, 1991
Cogen P, Daneshwar L, Metzger AK, Edwards MSB: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8: 279–285, 1990
Saylors RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721–4723, 1991
Friedman HS, Burger PC, Bigner SH Trojanowski JQ, Brodeur GM, He X, Wikstrand CJ, Kurtzberg J, Berens ME, Halperin EC, Bigner DD: Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplanted xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 130: 472–484, 1988
Bigner SH, Friedman SH, Vogelstein B, Oaks WJ, Bigner DD: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50: 2347–2350, 1990
MacGregor DN, Ziff EB: Elevated c-myc expression in childhood medulloblastomas. Ped Res 28: 63–68, 1990
Rouah E, Wilson DR, Armstrong DL, Darlington CJ: N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system. Cancer Res 49: 1797–1801, 1989
Wasson JC, Saylors RL, Zelter P, Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM: Oncogene amplification in Pediatric brain tumors. Cancer Res 50: 2987–2990, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahmed Rasheed, B.K., Bigner, S.H. Genetic alterations in glioma and medulloblastoma. Cancer Metast Rev 10, 289–299 (1991). https://doi.org/10.1007/BF00554791
Issue Date:
DOI: https://doi.org/10.1007/BF00554791